FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Merck | taranabant

Merck kills controversial obesity med

Tools

Merck has pulled the plug on its obesity drug taranabant, saying that efficacy and adverse events both increased at higher doses. Merck Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Merck   taranabant